VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer <i>in vivo</i>Guangbo Kang, He Huang, Ruowei Li et al.|Cancer Biology and Medicine|2021Cited by 19